Abstract
Advanced heart failure refractory to medical therapy can result in patients presenting with progressively worsening hypoperfusion and cardiogenic shock. Temporary mechanical circulatory support is often necessary as a bridge to heart transplant or durable ventricular assist devices. These devices increase cardiac output. Several options are available for left ventricular support. With the exception of venoarterial extracorporeal membrane oxygenation, all other devices decrease left ventricular end-diastolic pressure. The choice of device should be driven by patient needs and the treating teams comfort. Timely identification of cardiogenic shock and use of shock teams are potential strategies that can help improve survival.
| Original language | English |
|---|---|
| Pages (from-to) | 235-249 |
| Number of pages | 15 |
| Journal | Interventional Cardiology Clinics |
| Volume | 10 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 2021 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc.
Funding
Dr E.Y. Birati reports support paid to the University of Pennsylvania from Medtronic Inc and Impulse Dynamics Ltd. The other authors have no relevant disclosures.
Keywords
- Cardiogenic shock
- CentriMag
- ECMO
- End-stage heart failure
- IABP
- Impella
- ProtekDuo
- Rotaflow
- TandemHeart